According to Barclays September 2018 European Consumer Staples Report the global cannabis industry could be worth USD$272 billion by 2028. European government-subsidized health care systems with a current budget of $1.3 trillion in spending will bring the medical cannabis market to dominate Europe and become the largest medical marijuana market in the world.

A 2018 cannabis report from Deloitte found 74 percent of people surveyed have had prior experience with recreational cannabis, and 41 percent have consumed it in the past five years. Not surprisingly, the study found that approximately one-third of cannabis consumers indicated an interest in buying products online.

Hill and Knowlton report that environmental, social and governance indicators have never been more important to large investors. The same research found that 57% of medical patients prefer organic cannabis. The survey found 43% of recreational users had the same preference and were willing to pay a premium for the product. Now, the world is watching as Canada stepped into the spotlight in late 2018 as the first G7 country to legalize recreational cannabis nationwide.

It is in this context that we are operating. Located in Sydney, where Australia’s legal cannabis market is forecast to grow from $52 million in 2018 to $1.2 billion in 2027 making it the fifth largest in the world.

We have operation in three countries, Australia, New Zealand, and Italy . The Company we work with have vertical integration processes and control more than one stage of the supply chain. The processes in turning raw material into products and delivering it to the consumer, give these companies total control of the entire manufacturing process to ensure its bottom lines are achieved.

These companies import, export and wholesale cannabis and cannabis-based products both high in CBD and THC. In Australia and New Zealand, target markets are pharmacies, hospitals, medical practices, and practitioners. Internationally, Our companies target the wholesale supply of CBD biomass and extracted cannabidiol oil based products. The Company has supply agreements with leading cannabis cultivators and manufacturers in Canada, The United States, and Europe, which include internationally recognized brands and products.